Exelway Inc.
USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2015–2016. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04R (Loudspeakers, Microphones, Gramophone Pick-ups OR Like Acoustic Electromechanical TRANSDUCERS; Deaf-aid SETS; Public Address Systems).
The verdict
According to USPTO PatentsView, Exelway ranks #46,624 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.
- #46,624
- of 49,997 US assignees by volume
- 3rd percentile
- by Innovation Score (15.8/100)
- 7.6
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R46624 · Foreign Corporation #46,624 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #46,624/49,997
- PHOTO-FINISH Exair
- CPC-NARROW H04R · 2 areas
- INNOV-LOW 15.8/100
- CLAIMS-SPARSE 7.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Exair Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Exelway’s 15.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Exelway
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Exelway · this assignee 16
Exelway · this assignee
16 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Exelway's Innovation Score is 15.8/100 (3rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Exelway?
Each dot is one of Exelway’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Exelway’s own 7.6 claims/patent is at or below the 15.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Exelway's grants concentrate
Exelway Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under H04R (Loudspeakers, Microphones, Gramophone Pick-ups OR Like Acoustic Electromechanical TRANSDUCERS; Deaf-aid SETS; Public Address Systems). Peak complete grant year is 2015 (3 grants) versus a trough of 2 in 2016. By volume, Exelway sits between Exair Corporation and Exonhit Therapeutics, SA.
Who files at Exelway's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Exair
Exair Corporation
5 patents
- Exalt Solutions
Exalt Solutions, Inc.
5 patents
- Excelsior
Excelsior Inc.
5 patents
- Exela Sterile Med…
Exela Sterile Medicines LLC
5 patents
- Exhalation Techno…
Exhalation Technology Limited
5 patents
- Exhaustless
Exhaustless, Inc.
5 patents
- Exoiq
Exoiq GMBH
5 patents
- Exonhit Therapeut…
Exonhit Therapeutics, SA
5 patents
- Exelway ◀
Exelway Inc.
5 patents
What this shows Exelway holds 5 patents at rank #46,487, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Exelway
By rank, the assignees closest to #46,487 in granted patent volume.
- Exair Corporation #46,483 · 5 patents
- Exalt Solutions, Inc. #46,484 · 5 patents
- Excelsior Inc. #46,485 · 5 patents
- Exela Sterile Medicines LLC #46,486 · 5 patents
- Exhalation Technology Limited #46,488 · 5 patents
- Exhaustless, Inc. #46,489 · 5 patents
- Exoiq GMBH #46,490 · 5 patents
- Exonhit Therapeutics, SA #46,491 · 5 patents
Leaders in H04R (Loudspeakers)
Other assignees with the most granted patents in Exelway's primary technology class.
Exelway's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
16 3rd percentile higher than 3% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 60.0% |
| 2016 | 2 | 40.0% |
Which technologies does Exelway Inc. patent most?
Top 2 of 2 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Exelway Inc.'s patent record in context - here's where to go next.
- Exelway Inc.'s lead technology class is H04R (Loudspeakers, Microphones, Gramophone Pick-ups OR Like Acoustic Electromechanical TRANSDUCERS; Deaf-aid SETS; Public Address Systems), 100% of its portfolio - see every assignee active in that class. Explore H04R
- Ranked #46,624 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Exelway Inc. against Exair Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 15.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.